MX2011009144A - Adsorbente de fosfato. - Google Patents

Adsorbente de fosfato.

Info

Publication number
MX2011009144A
MX2011009144A MX2011009144A MX2011009144A MX2011009144A MX 2011009144 A MX2011009144 A MX 2011009144A MX 2011009144 A MX2011009144 A MX 2011009144A MX 2011009144 A MX2011009144 A MX 2011009144A MX 2011009144 A MX2011009144 A MX 2011009144A
Authority
MX
Mexico
Prior art keywords
treatment
phosphate adsorbent
phosphate
hyperphosphataemia
magnesium
Prior art date
Application number
MX2011009144A
Other languages
English (en)
Inventor
Peter Geisser
Erik Philipp
Gisela Witzel
Original Assignee
Vifor Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40627528&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2011009144(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vifor Int Ag filed Critical Vifor Int Ag
Publication of MX2011009144A publication Critical patent/MX2011009144A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Abstract

El objetivo de la presente invención son composiciones que comprenden una mezcla de sales de calcio, magnesio y hierro para el uso como una preparación farmacéutica para adsorción de fosfato, especialmente para el uso como preparaciones farmacéuticas para el tratamiento de hiperfosfatemia, deficiencia renal crónica así como para el tratamiento de pacientes con hemodiálisis.
MX2011009144A 2009-03-02 2010-03-01 Adsorbente de fosfato. MX2011009144A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09154107 2009-03-02
PCT/EP2010/052551 WO2010100112A1 (en) 2009-03-02 2010-03-01 Phosphate adsorbent

Publications (1)

Publication Number Publication Date
MX2011009144A true MX2011009144A (es) 2011-09-15

Family

ID=40627528

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011009144A MX2011009144A (es) 2009-03-02 2010-03-01 Adsorbente de fosfato.

Country Status (20)

Country Link
US (1) US20120052135A1 (es)
EP (1) EP2403506A1 (es)
JP (1) JP2012519201A (es)
KR (1) KR101497003B1 (es)
CN (1) CN102341111A (es)
AR (1) AR076070A1 (es)
AU (1) AU2010220396B2 (es)
BR (1) BRPI1009110A2 (es)
CA (1) CA2753364A1 (es)
CL (1) CL2011002130A1 (es)
IL (1) IL214509A0 (es)
MX (1) MX2011009144A (es)
MY (1) MY162484A (es)
NZ (1) NZ594730A (es)
PE (1) PE20120327A1 (es)
RU (1) RU2527682C2 (es)
SG (1) SG173887A1 (es)
TW (1) TWI454267B (es)
WO (1) WO2010100112A1 (es)
ZA (1) ZA201106305B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0913525D0 (en) * 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
EP2548562A1 (de) 2011-07-18 2013-01-23 SeBo GmbH Kombinationstherapie mit Eisen-basierenden Phosphatadsorbern
JP6417339B2 (ja) * 2013-03-08 2018-11-07 ヴィダシム・インコーポレーテッド 金属イオン−機能性繊維成分錯体組成物、その調製および使用
EP2805603B1 (de) * 2013-05-22 2017-01-11 CLAAS E-Systems KGaA mbH & Co KG Vorrichtung und Verfahren zur Überwachung der Schneidenschärfe
WO2015181205A1 (en) 2014-05-28 2015-12-03 Biaqua B.V. Method for removing phosphate from water fractions
CN105232767A (zh) * 2015-09-29 2016-01-13 江苏锦宇环境工程有限公司 一种制备吸附磷酸盐的药物制剂的方法
CN107397758A (zh) * 2016-05-19 2017-11-28 欣凯医药化工中间体（上海）有限公司 一种磷结合剂及其制备方法
CN107397760B (zh) * 2016-05-19 2021-07-30 欣凯医药化工中间体（上海）有限公司 基于铁的氢氧化物－低分子量糖的磷结合剂、其制备方法及其应用
ES2927438T3 (es) * 2017-05-31 2022-11-04 Mars Inc Procedimientos de diagnóstico y tratamiento de la enfermedad renal crónica
LT3930686T (lt) 2019-02-28 2023-10-10 Renibus Therapeutics, Inc. Naujos geležies kompozicijos ir jų gamybos bei naudojimo būdai
US20210130251A1 (en) * 2019-07-17 2021-05-06 Water Warriors Inc. Adsorbent Structures for the Removal of Phosphates and Ammonia from Wastewater and Methods of Use
US20210022315A1 (en) * 2019-07-23 2021-01-28 Société des Produits Nestlé S.A. Methods and compositions with renal benefits for felines
CN113029978A (zh) * 2019-12-25 2021-06-25 远大生命科学(辽宁)有限公司 一种检测含镧试剂的磷结合能力的方法
CN111905736B (zh) * 2020-07-23 2021-10-26 安徽工业大学 一种半胱氨酸功能化改性的羟基氧化铁、电催化剂、制备方法及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970079A (en) * 1989-06-05 1990-11-13 Purdue Research Foundation Method and composition of oxy-iron compounds for treatment of hyperphosphatemia
DE19547356A1 (de) * 1995-12-19 1997-06-26 Vifor Int Ag Adsorbens für Phosphat aus wäßrigem Medium, dessen Herstellung und Verwendung
GB9720061D0 (en) * 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
DE19917705C1 (de) * 1999-04-20 2000-12-28 Vitasyn Gmbh Mittel zur Therapie von Hyperphosphatämie
DE102004031181A1 (de) * 2004-06-28 2006-01-19 Vifor (International) Ag Phosphatadsorbens
MY157620A (en) * 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
EP1932808A1 (en) * 2006-12-14 2008-06-18 Novartis AG Iron(III)-Carbohydrate based phosphate adsorbent

Also Published As

Publication number Publication date
TWI454267B (zh) 2014-10-01
CL2011002130A1 (es) 2012-03-23
WO2010100112A1 (en) 2010-09-10
AU2010220396B2 (en) 2013-10-17
CA2753364A1 (en) 2010-09-10
SG173887A1 (en) 2011-10-28
IL214509A0 (en) 2011-09-27
MY162484A (en) 2017-06-15
CN102341111A (zh) 2012-02-01
AR076070A1 (es) 2011-05-18
US20120052135A1 (en) 2012-03-01
AU2010220396A1 (en) 2011-09-01
EP2403506A1 (en) 2012-01-11
JP2012519201A (ja) 2012-08-23
TW201034677A (en) 2010-10-01
PE20120327A1 (es) 2012-04-11
NZ594730A (en) 2013-06-28
KR20110128329A (ko) 2011-11-29
BRPI1009110A2 (pt) 2019-09-24
ZA201106305B (en) 2012-05-30
RU2011140017A (ru) 2013-04-10
KR101497003B1 (ko) 2015-02-27
RU2527682C2 (ru) 2014-09-10

Similar Documents

Publication Publication Date Title
MX2011009144A (es) Adsorbente de fosfato.
UA110473C2 (uk) Спосіб лікування раку за допомогою пухлиноасоційованого антигену, отриманого із цикліну d1
MX2014009757A (es) Derivados de isoindolina, composiciones farmaceuticas que los contienen y su uso en terapia.
MX343135B (es) Compuestos de tipo fumagilol y métodos de realización y uso de los mismos.
WO2011130753A3 (en) Functionalized nano- and micro-materials for medical therapies
MX2013002864A (es) Triazina-oxadiazoles.
TN2011000200A1 (en) Combination therapy with peptide epoxyketones
GB201118656D0 (en) New compounds
MX340822B (es) Formulaciones para suministro oral de adsorbentes en el intestino.
IN2012MN02591A (es)
MY165624A (en) N-acylsulfonamide apoptosis promoters
WO2012024530A3 (en) Therapeutic peptide-polymer conjugates, particles, compositions, and related methods
MX349004B (es) Nuevos compuestos.
MX2011008634A (es) Derivados de aminotetralina composiciones farmaceuticas que los contienen y su uso en terapia.
TN2012000457A1 (en) Fe(iii) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias
WO2009121872A3 (en) Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
IN2015DN01164A (es)
MX2013003060A (es) Terapia de combinacion para tratar infeccion por hcv.
IN2015DN01165A (es)
WO2014169094A3 (en) Nhe3-binding compounds and methods for inhibiting phosphate transport
WO2014044794A3 (en) Pharmaceutical composition
WO2013071056A3 (en) Combination drug therapy for the treatment of solid tumors
MX2012008328A (es) Derivados de pirazina.
WO2012053013A3 (en) Pharmaceutical compositions of anti-acne agents
WO2012092305A3 (en) Nanonized iron compositions and methods of use thereof